NSB Receives A$2.2M Research & Development Tax Refund

Mar 20, 2024 at 3:00 AM UTC · Issued by Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release.